Heron Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$905K Buy
7,844
+305
+4% +$34.6K 0.49% 46
2023
Q1
$802K Buy
7,539
+666
+10% +$71.9K 0.44% 49
2022
Q4
$781K Buy
6,873
+600
+10% +$61.3K 0.52% 43
2022
Q3
$540K Buy
6,273
+155
+3% +$13.8K 0.33% 68
2022
Q2
$558K Sell
6,118
-1,055
-15% -$93.5K 0.34% 68
2022
Q1
$589K Buy
7,173
+1,776
+33% +$140K 0.31% 72
2021
Q4
$442K Buy
5,397
+70
+1% +$5.58K 0.24% 87
2021
Q3
$400K Sell
5,327
-30
-0.6% -$2.28K 0.22% 92
2021
Q2
$417K Buy
5,357
+429
+9% +$31.9K 0.24% 89
2021
Q1
$362K Buy
4,928
+902
+22% +$66.5K 0.22% 94
2020
Q4
$323K Sell
4,026
-58
-1% -$4.44K 0.22% 97
2020
Q3
$317K Buy
4,084
+320
+9% +$25.1K 0.25% 87
2020
Q2
$276K Buy
3,764
+262
+7% +$19.7K 0.25% 93
2020
Q1
$277K Hold
3,502
0.28% 82
2019
Q4
$285K Buy
+3,502
New +$288K 0.24% 100

Other funds holding MRK

Heron Financial Group's MRK Position: Q2 2023 in Review

Heron Financial Group increased its Merck (MRK) stake by 4% in Q2 2023, buying an estimated $34.6K and bringing the position to 7,844 shares worth $905K. The position accounts for 0.49% of the portfolio, ranked #46.

Heron Financial Group first reported a position in MRK in Q4 2019 and has held it in 15 quarters since. 3,255 funds tracked by Wall St. Rank hold MRK as of Q2 2023.

  • Heron Financial Group held 7,844 shares of Merck worth $905K as of Q2 2023.
  • Heron Financial Group bought 305 Merck shares in Q2 2023, an estimated $34.6K.
  • Merck made up 0.49% of Heron Financial Group's portfolio in Q2 2023, its #46 holding.
  • Heron Financial Group first reported a position in Merck in Q4 2019 and has held it in 15 quarters since.
  • 3,255 funds tracked by Wall St. Rank held Merck as of Q2 2023.

Based on Heron Financial Group's 13F filing for Q2 2023, filed 10 Aug 2023.